NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00003013,Chemotherapy Plus Surgery in Treating Women With Breast Cancer,https://clinicaltrials.gov/study/NCT00003013,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining surgery with chemotherapy may kill more tumor cells. It is not yet known which treatment regimen is more effective for breast cancer.

PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy plus surgery in treating women who have breast cancer.",NO,Breast Cancer,DRUG: CMF regimen|DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|DRUG: fluorouracil|DRUG: methotrexate|DRUG: paclitaxel|DRUG: tamoxifen citrate|PROCEDURE: conventional surgery|RADIATION: radiation therapy,,,,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",,FEMALE,"ADULT, OLDER_ADULT",PHASE3,450,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000065593|INT-23/96|EU-97001,1996-10,,2009-03,2003-01-27,,2013-09-17,"Kaiser Franz Josef Hospital, Vienna, A-1100, Austria|Radiotherapy Institute, Ostrava-Poruba, 70852, Czech Republic|University of Tartu, Tartu, 51003, Estonia|Frauenklinik Vom Roten Kreuz, Munich, 80637, Germany|Semmelweis University, Budapest, 1082, Hungary|Uzsoki Hospital, Budapest, 1145, Hungary|Policlinico Monteluce, Perugia, 06122, Italy|Ospedale St. Santa Chiara, Pisa, 56100, Italy|Centro di Riferimento Oncologico - Aviano, Trento, 38100, Italy|Universita Degli Studi di Udine, Udine, 33100, Italy|Ospedale San Bortolo, Vicenza, 36100, Italy|Latvian Cancer Center, Riga, 1079, Latvia|Regional Center of Oncology, Bydgoszcz, 85-796, Poland|Jagiellonian University, Krakow (Cracow), 31-826, Poland|Szpital Kliniczny NR 1, Poznan, PL-61-878, Poland|Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, 02-781, Poland|Russian Academy of Medical Sciences Cancer Research Center, Moscow, 115478, Russian Federation|Moscow Clinical Dispenser, Moscow, 129128, Russian Federation|N. A. Semashko Central Clinical Hospital, Moscow, 129128, Russian Federation|Regional Oncology Clinic, Murmansk, 183047, Russian Federation|Petrov Research Institute of Oncology, Saint Petersburg, 197758, Russian Federation|St. Elizabeth Cancer Institute Hospital, Bratislava, SK-81250, Slovakia|Hospital de la Santa Cruz I Sant Pau, Barcelona, 08025, Spain|Hospital General Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Clinico Universitario - Malaga, Malaga, 29010, Spain|Instituto Valenciano De Oncologia, Valencia, 46009, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain",
